IGIM
WX

I.G. Investment Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

I.G. Investment Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-37,978
Closed -$1.25M – 953
2014
Q2 		$1.25M Buy
37,978
+23,838
+169% +$816K ﹤0.01% 575
2014
Q1 		$521K Buy
+14,140
New +$519K ﹤0.01% 704

Other funds holding WX

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

I.G. Investment Management's WX Position: Q3 2014 in Review

I.G. Investment Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2014, closing a stake of 37,978 shares — an estimated $1.25M sold.

I.G. Investment Management first reported a position in WX in Q1 2014 and held it in 2 quarters. The position peaked at $1.25M in Q2 2014. 157 funds tracked by Wall St. Rank hold WX as of Q3 2014.

  • I.G. Investment Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2014 after selling out during the quarter.
  • I.G. Investment Management sold 37,978 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2014, an estimated $1.25M.
  • I.G. Investment Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 2 quarters.
  • I.G. Investment Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.25M in Q2 2014.
  • 157 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2014.

Based on I.G. Investment Management's 13F filing for Q3 2014, filed 12 Nov 2014.